| 标题 |
Antisense oligonucleotide DGAT-2 inhibitor, ION224, for metabolic dysfunction-associated steatohepatitis (ION224-CS2): results of a 51-week, multicentre, randomised, double-blind, placebo-controlled, phase 2 trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet 作者:Rohit Loomba; Erin E. Morgan; Keyvan Yousefi; Dan Li; Richard S. Geary; et al 出版日期:2025-08-01 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)